Report Overview

The global microbial fermentation technology market was pegged at US$ 28.5billion in 2021 and is expected to witness a CAGR of 6.5% during the forecast period.

Market Fundamentals 

A cutting-edge field called "microbial fermentation technology" uses microorganisms to generate useful chemicals. The chemical, pharmaceutical, energy, material, and food industries are still researching the utilisation of fungi, bacteria, and eukaryotic cells like insect cells and CHO cells. Microorganisms including bacteria, yeast, fungus, and their enzymes participate in fermentation. Based on DNA sequences, the biotechnology programme chooses bacteria strains for fermentation. Furthermore, there are four different forms of fermentation: those that produce external metabolites, intracellular components, biomass, and substrate transformation. Molds, bacteria, algae, yeast, plant or animal cells are only a few of the organisms that can be used in microbial fermentation technology.

[9732423]

Market Dynamics

The demand for alternative products in the chemical industry, such as alcohols, alkaloids, amino acids, and enzymes, has surged as a result of rising gas prices and the depletion of fossil fuel reserves. Utilizing products from the global market for microbial fermentation technology will enable the acquisition of these goods. In the upcoming years, it is anticipated that this tendency will propel the global market for microbial fermentation technology. Numerous industries, including those in the energy, materials, food and beverage, pharmaceutical, and chemical sectors, employ the products from the global market for microbial fermentation technology. Some of the main products produced through the application of solutions in the global market for microbial fermentation technology include ethanol, citric acid, and acetic acid.

Market Ecosystem

The global microbial fermentation technology market has been analysed into three perspectives by product, end user and region. 

Microbial Fermentation Technology Market by Product

[123123]

Based on product, the microbial fermentation technology market has been segmented into medical & antibiotics, industrial, alcohol and beverages, food and feed products. The medical & antibiotics segment dominated the market during forecast period.  The strong demand for antibiotics around the world, the growing interest in microbial metabolite research, and the release of new antibiotics onto the market are all factors contributing to the segment's dominance. The production of microbial fermentation is essential for the creation of antibiotics. For instance, according to a number of studies, 70–80% of all known antibiotics come from a single type of bacteria. However, the alcohol & beverages product segment is anticipated to grow at the fastest rate in the global market for microbial fermentation technology over the course of the forecast period due to factors such as the rising popularity of alcoholic beverages among young people and millennials, the growing urban population, technological advancements, ongoing product launches in the sector, and an increase in the number of lounges and bars. While some factors, such as strict regulations on alcoholic beverage advertising and growing awareness about the negative effects of excessive alcohol consumption, are expected to limit the segment's market share in the future, demand for flavoured alcoholic beverages is anticipated to increase over the forecast period due to consumer demand for new flavours.

Microbial Fermentation Technology Market by End User

Based on end user, the microbial fermentation technology market has been segmented into bio-pharmaceuticals industries, food & feed industry, contract research organizations (CROs) and contract manufacturing organizations (CMOs) and academic research institutes. The market was dominated by and had the largest share of CROs and CDMOs. Since the majority of innovation in the bioprocess industry is produced by smaller companies with limited resources, qualified personnel, and capacity, the CROs and CDMOs are quickly emerging as the preferred choice for biotherapeutics makers. The continually expanding clinical pipeline of biologics is yet another element that is anticipated to contribute to the expansion of this market. 

Microbial Fermentation Technology Market by Region

Based on region, the microbial fermentation technology market has been segmented into North America, Europe, Asia Pacific and Rest of the World. In the upcoming years, North America is anticipated to experience significantly higher growth. This is due to the increasing involvement of companies in biologics research and product development as well as the existence of a sizable number of contract development companies in the area. Another important element that has shaped the North American industry is the robust regulatory environment. The American Food and Drug Administration (US FDA) is constantly working to enhance the regulations governing the legal environment for, and promotion of, biopharmaceutical goods. However, the Asia Pacific is the fastest growing region during forecast period. This is because Asian nations are now recognised as a centre for outsourcing in the biopharmaceutical industry. According to estimates, Asian businesses—both domestic heavyweights and global behemoths—will construct approximately half of the new bioprocessing facilities worldwide.

Competitive Landscape

 Some of the prominent market player in the global microbial fermentation technology include 

• Biocon Ltd
• Amyris, Inc.
• BioVectra Inc.
• Danone Uk
• F. Hoffmann-La Roche Ltd
• Koninklijke DSM NV
• Lonza
• Novozymes A/S
• TerraVia Holdings, Inc.
• BIOZEEN 

Strategic development

• In April 2020, umitomo Chemicals made a large investment of 30 million into a partnership with the US-based biotechnology firm CONAGEN. The goal of this investment is to create cutting-edge, highly functional products that make the best possible use of biological microorganisms.
• In June 2019, For the distribution of the biological pesticide flipper, Bayer and Alpha bio agreed into a cooperative arrangement. Additionally, Bayer has a worldwide exclusive licence through this deal from Alpha Bio to market flippers for both agricultural and non-agricultural uses.

Frequently Asked Questions About This Report